Institute of Hematology and Hospital of Blood Disease

Tianjin 300020

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Leukemia

Studies at this site

• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed